DBV Technologies (DBVT) Operating Expenses (2020 - 2026)
DBV Technologies (DBVT) reported Operating Expenses of $48.8 million for Q1 2026, up 78.1% year-over-year from $27.4 million in Q1 2025, and up 6.8% quarter-over-quarter from $45.7 million in Q4 2025.
DBV Technologies (DBVT) Operating Expenses (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of Operating Expenses data on file, last reported at $48.8 million in Q1 2026.
- Operating Expenses for Q1 2026 came in at $48.8 million, up 78.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $174.1 million (up 47.34% YoY), and the FY2025 annual result was $152.7 million, up 26.46% from the prior year.
- Operating Expenses improved to $48.8 million in Q1 2026 per DBVT's latest filing, from $45.7 million in the prior quarter.
- Over five years, Operating Expenses peaked at $48.8 million in Q1 2026 and troughed at $19.3 million in Q1 2022.
- A 5-year average of $30.3 million and a median of $27.4 million in 2025 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses soared 123.71% in 2022, then sank 43.36% in 2023.
- A 5-year view of Operating Expenses shows it stood at $36.7 million in 2022, then slumped by 43.36% to $20.8 million in 2023, then climbed by 17.2% to $24.4 million in 2024, then soared by 87.49% to $45.7 million in 2025, then climbed by 6.8% to $48.8 million in 2026.
- Business Quant data shows DBVT's Operating Expenses at $48.8 million in Q1 2026, $45.7 million in Q4 2025, and $37.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 15.76 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -67.40 Mn |
| 10 | DBV Technologies | 7.53 Bn | 7.30 Bn | -3.90 Mn | 48.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.80 Mn |
| Dec 31, 2025 | 45.70 Mn |
| Sep 30, 2025 | 37.05 Mn |
| Jun 30, 2025 | 42.58 Mn |
| Mar 31, 2025 | 27.40 Mn |
| Dec 31, 2024 | 24.37 Mn |
| Sep 30, 2024 | 31.40 Mn |
| Jun 30, 2024 | 35.00 Mn |
| Mar 31, 2024 | 29.96 Mn |
| Dec 31, 2023 | 20.80 Mn |
| Sep 30, 2023 | 20.64 Mn |
| Jun 30, 2023 | 27.36 Mn |
| Mar 31, 2023 | 23.36 Mn |
| Dec 31, 2022 | 36.71 Mn |
| Sep 30, 2022 | 20.09 Mn |
| Jun 30, 2022 | 25.35 Mn |
| Mar 31, 2022 | 19.32 Mn |
| Dec 31, 2021 | 16.41 Mn |
| Sep 30, 2021 | 25.69 Mn |
| Jun 30, 2021 | 29.65 Mn |